Thursday, April 18, 2024

Preprint: Highly Pathogenic Avian Influenza A (H5N1) clade 2.3.4.4b Virus detected in dairy cattle

 

#18,013

Yesterday researchers from the Department of Veterinary Diagnostic and Production Animal Medicine, College of Veterinary Medicine, at Iowa State University published a preprint with additional detailed information the HPAI H5N1 virus that spilled over from birds into cows - and a human and several cats - in Texas earlier this year (see graphic above)

While the exact route of introduction of the virus to cattle remains unknown, based on the available evidence, the authors hypothesize:

. . .  wild birds may spread the virus through direct contact or contamination of water sources or feed staffs utilized by dairy cattle or other animals such as skunks. Consequently, other cattle in the herd, workers and domestic felids on dairy farms may contract the virus through direct contact with infected cattle or after consuming raw colostrum and milk from infected cattle. The detection of the same strain of HPAI viruses in various wild bird species, such as blackbirds and common grackles in Texas and Canada geese in  Wyoming (Central Flyway), provides further support for this hypothesis. 

Another potential transmission scenario involves bovine-to-bovine spread. Recently, the USDA has verified the presence of this HPAI virus strain in dairy herds located in Idaho, Michigan, Ohio, North Carolina, and South Dakota (Link). In these cases, a documented history exists of cattle introduction from farms in the initial outbreak area, further supporting the  hypothesis that lateral transmission can occur among cattle.

Although human infections with this relatively new HPAI H5N1 clade 2.3.4.4b virus remain rare, the authors write:

. . .  37 new mammal species have been afflicted since  2021. The majority of these cases involve wild terrestrial mammals such as foxes, skunks, bears,  bobcats, and raccoons (9, 23, 24). Intriguingly, there have been sporadic infections among  domestic pets like domestic cats and dogs (25), as well as marine mammals, including dolphins and sea lions (26). 

Moreover, from January 2022 to April 2023, eight documented human cases  of H5N1 influenza from clade 2.3.4.4b have been recorded, several of which were severe or fatal  (https://www.cdc.gov.flu/), underlining the gravity of this situation.


I've reproduced the link, and some excerpts from this 19-page public domain summary below, but you'll want to follow the link to read it in its entirety.


Highly Pathogenic Avian Influenza A (H5N1) clade 2.3.4.4b Virus detected in dairy cattle
Xiao Hu, Anugrah Saxena, Drew R. Magstadt, Phillip C. Gauger, Eric Burrough, Jianqiang Zhang, Chris Siepker, Marta Mainenti, Patrick Gorden, Paul Plummer, Ganwu Li
doi: https://doi.org/10.1101/2024.04.16.588916
This article is a preprint and has not been certified by peer review 

Preview PDF

Abstract

The global emergence of highly pathogenic avian influenza (HPAI) A (H5N1) clade 2.3.4.4b viruses poses a significant global public health threat. Until March 2024, no outbreaks of this virus clade had occurred in domestic cattle. We genetically characterize HPAI viruses from dairy cattle showing an abrupt drop in milk production. They share nearly identical genome sequences, forming a new genotype B3.13 within the 2.3.4.4b clade.

B3.13 viruses underwent two reassortment events since 2023 and exhibit critical mutations in HA, M1, and NS genes but lack critical mutations in PB2 and PB1 genes, which enhance virulence or adaptation to mammals. The PB2 E627K mutation in a human case underscores the potential for rapid evolution post-infection, highlighting the need for continued surveillance to monitor public health threats.

          (SNIP)

In addition to being the first documented occurrence of HPAI A (H5N1) clade 2.3.4.4b virus infection in domestic dairy cattle, early pathology observations in this outbreak revealed an apparent tissue tropism for mammary gland in lactating domestic dairy cattle (personnel communication).

Prior to this incident, the clade 2.3.4.4b IAV has typically caused systemic and respiratory diseases in wild mammals (9). Gross and microscopic lesions in wild mammals were frequently observed in organs such as the lung, heart, liver, spleen, and kidney, with some cases resulting in lesions in the brain leading to neurological signs.

Furthermore, while it is widely  recognized that certain strains of HPAI H5N1 clade 2.3.4.4b virus can breach the blood-brain barrier (9, 23, 25, 27), this is the first instance where the virus may penetrate the blood-milk barrier and be present in milk, raising potential public health concerns.  

          (SNIP)

Notably, all HPAI  viruses originating from dairy cattle and cats exhibit consistent amino acid residues in the HA gene, including 137A, 158N, and 160A, which have been documented to enhance the affinity of avian influenza viruses for human-type receptors (15, 16). Additionally, these dairy cattle derived and cat-derived HPAI viruses harbor key virulence-increasing amino acid residues, such  as 30D, 43M, and 215A in M1 (17-19), as well as 42S, 103F, and 106M in NS1(20). 

The  presence of these amino acid mutations raises legitimate concerns regarding the potential for  cross-species transmission to humans and other mammalian species. It is noteworthy that crucial mutations associated with mammalian host adaptation and enhanced transmission, specifically residues 591K, 627K/V/A, 701N, in PB2 (18, 21, 22), and 228S, along with the virulence increasing residue 66S in PB1-F2(30), were conspicuously absent in all HPAI virus strains derived from dairy cattle and cats

This observation suggests that the current overall risk to  human health is relatively low. However, it is imperative to recognize that influenza viruses have  the capacity for rapid evolution within their host environments post-infection. A recent human case with direct contact with infected dairy cattle revealed a genetic change (PB2 E627K) (LINK), indicating the potential for adaptation or transmission events. This underscores the dynamic nature of influenza viruses and the importance of continued surveillance and vigilance in monitoring potential  threats to human health. 

          (Continue . . . )

 

While the genetic analysis still shows a virus not quite ready for prime-time, we are seeing only a tiny slice of what is going on in the wild.  Officially, Texas has only reported a single spillover into mammalian wildlife (a striped skunk in 2023 - see map below) but is a pretty safe assumption that many others have gone unreported. 


Over the past two years nearly half the states in the country haven't reported a single spillover - and while infected animals may die in remote and difficult to access places where their carcasses are quickly scavenged -  this probably speaks more to our reluctance to aggressively look for cases than how often they actually occur. 

While the USDA cites logistical problems and concerns over laboratory capacity, we appear embarked on a similar path with livestock testing, which remains both limited and voluntary. 

As long as the virus remains poorly adapted to humans, it is possible what we don't know won't hurt us. But given the enormous strides HPAI H5 has made over the past 3 years, any purported `bliss from  ignorance' may prove short-lived. 

Wednesday, April 17, 2024

APHIS/USDA Updated FAQ On Detection of HPAI (H5N1) in Dairy Herds


#18,012

A little over two weeks after their first FAQ (Frequently Asked Questions) on HPAI H5N1 in dairy cattle we have new update, dated April 16th.  I've selected some excerpts to highlight, but you'll want to follow the link to read the full 5-page document.

I'll have a brief comment after there break.


What is the appropriate nomenclature for this virus, now that it has appeared in dairy cows? 

From USDA’s perspective, highly pathogenic avian influenza or H5N1 are the most scientifically accurate terms to describe this virus. This is also consistent with what the scientific community has continued to call the virus after it has affected other mammals. As a reminder, genomic sequencing of viruses isolated from cattle indicates there is no change to this virus that would make it more transmissible to or between humans, and the CDC considers risk to the public to be low at this time. However, people with more exposure to infected animals do have a greater risk of infection. Since the virus is not highly pathogenic in mammals, H5N1 is the most fitting of the two scientifically correct options. It is important to note that “highly pathogenic” refers to severe impact in birds, not necessarily in humans or cattle.

How did these cattle contract H5N1? 

Wild migratory birds are believed to be the original source of the virus. However, the investigation to date also includes some cases where the virus spread was associated with cattle movements between herds. Additionally, we have similar evidence that the virus also spread from dairy cattle premises back into nearby poultry premises through an unknown route. 

As a reminder, analysis sequences of viruses found in cattle thus far have not found changes to the virus that would make it more transmissible to humans and between people. While cases among humans in direct contact with infected animals are possible, CDC believes that the current risk to the public remains low. 

Is this the same virus that has been in circulation among wild and commercial flocks in recent months, or is this a different virus? 

Tests so far indicate that the virus detected in dairy cows is H5N1, Eurasian lineage goose/Guangdong clade 2.3.4.4b. This is the same clade that has been affecting wild birds and commercial poultry flocks and has caused sporadic infections in several species of wild mammals, and neonatal goats in one herd in the United States. A full list can be found here. 

How is a case of H5N1 in cattle confirmed by USDA? 

USDA encourages producers to work with their veterinarians to report cases of sick cattle to State Animal Health Officials and their APHIS Veterinary Services Area Veterinarian in Charge. Veterinarians should submit samples to a National Animal Health Laboratory Network (NAHLN) laboratory for initial testing. Samples with non-negative test results are then submitted to the National Veterinary Service Laboratories in Ames, Iowa for confirmatory testing. USDA considers a positive test result from testing performed by the NVSL as confirmation, and NVSL carries out viral genome sequencing.

Combined with the recent detections of H5N1 in baby goats in Minnesota, is there reason to be concerned H5N1 may spread to mammals more commonly than previously believed? 

H5N1 has been found in wild birds, poultry flocks, several species of wild mammals, farm cats, and neonatal goats in one herd in the United States. A full list can be found here. Many species are susceptible to influenza viruses, including wildlife that often come into direct contact with wild birds. Many of these animals were likely infected after consuming or coming into contact with birds that were infected with H5N1. In the case of the neonatal goats in Minnesota, they were exposed to domestic birds (ducks and chickens) infected with H5N1 through shared pasture and a sole water source. However, recent testing indicates the virus has also been spread by cattle movements between herds. 

Has USDA confirmed at this point that cow-to-cow transmission is a factor? 

Yes, although it is unclear exactly how virus is being moved around. We know that the virus is shed in milk at high concentrations; therefore, anything that comes in contact with unpasteurized milk, spilled milk, etc. may spread the virus. Biosecurity is always extremely important, including movement of humans, other animals, vehicles, and other objects (like milking equipment) or materials that may physically carry virus. USDA APHIS is continuing to examine herds that have diagnosed cows to better understand the mode of transmission. To date, we have not found significant concentration of virus in respiratory related samples, which indicates to us that respiratory transmission is not a primary means of transmission.

Why is APHIS taking a voluntary, rather than mandatory, approach to testing dairy herds? 

It is important to keep in mind that while H5N1 is highly pathogenic in birds, that is not the case in cattle. At this time, APHIS does not think it would be practical, feasible or necessarily informative to require mandatory testing, for several reasons ranging from laboratory capacity to testing turnaround times. We are working actively to learn more about the emergence of H5N1 in cattle, but right now we are seeing that a small portion of the affected herds are becoming ill, and that the number of herds exhibiting symptoms is relatively small. For context, there are more than 26,000 dairy herds nationwide. We are strongly recommending testing before herds are moved between states, which should both give us more testing information, and should mitigate further state-to-state spread between herds.



I greatly appreciate the APHIS/USDA refusal to re-brand HPAI H5N1 as the industry promoted kinder-and-gentler BIAV (Bovine Influenza A Virus), but we are now a full three weeks since the first positive tests for HPAI in cattle (which took far too long to be performed), and still we have disappointingly little in the way of solid information on exactly how this virus is spreading, or how wide-spread it really is.

If this is truly the best we can do, then we need to greatly improve our capacity for laboratory testing and investigating outbreaks before the next `unprecedented' event occurs.  

The beef/dairy industry and government agencies are understandably keen to reassure the public of the safety of the food supply, and the very low risk to human health from infected cattle.  

But bland reassurances, repeated without accompanying evidence, soon loses its powers of persuasion. 

Preprint: Sustained Human Outbreak of a New MPXV Clade I Lineage in Eastern Democratic Republic of the Congo



#18,011

While the global health emergency for the international spread of a new clade (IIb) of Mpox (formerly Monkeypox) ended nearly a year ago, we continue to see sporadic infections around the globe, while a more dangerous clade I mpox virus continues to rage (>12,000 cases in 2023) in the DRC.

Last month we looked at a report in Eurosurveillance: Ongoing Mpox Outbreak in South Kivu Province, DRC Associated With a Novel Clade I Sub-lineage, which contained the first genomic analysis of samples from a previously unaffected region of the DRC (the city of Kamituga). 

That study revealed a novel clade I sub-linage had emerged - most likely from a zoonotic introduction - with changes that may render current CDC tests unreliable.

The changing epidemiology and genetic evolution of mpox clade I in central Africa has sparked a number of risks assessments over the past few months, including:

Today we have a preprint which further describes the outbreak of Mpox in the city of Kamituga. The authors warn in this 30-page PDF that the potential exists for this novel MPXV clade to eventually spread beyond the DRC, and potentially spark another global mpox outbreak. 

Due to its length I've only posted some excerpts, I'll have a postscript after the break. 
Emmanuel H. Vakaniaki, Cris Kaciat, Eddy Kinganda-Lusamaki, Aine O'Toole, Tony Wawina-Bokalanga, Daniel Mukadi-Bamuleka, Adrienne Amuri Aziza, Nadine Malyamungu-Bubala, Francklin Mweshi-Kumbana, Leandre Mutimbwa-Mambo, Freddy Belesi-Siangoli, Yves Mujula, Edyth Parker, Pauline-Chloe Muswamba-Kayembe, Sabin S. Nundu, Robert S. Lushima, Jean Claude Makangara Cigolo, Noella Mulopo-Mukanya, Elisabeth Pukuta Simbu, Prince Akil-Bandali, Hugo Kavunga, Koen Vercauteren, Nadia A. Sam-Agudu, Edward J Mills, Olivier Tshiani-Mbaya, Nicole A. Hoff, View ORCID ProfileAnne W Rimoin, Lisa E. Hensley, View ORCID ProfileJason Kindrachuk, Ahidjo Ayouba, Martine Peeters, Eric Delaporte, Steve Ahuka-Mundeke, Jean B. Nachega, Jean-Jacques Tamfum Muyembe, Andrew Rambaut, View ORCID ProfileLaurens Liesenborghs, Placide Mbala-Kingebeni
doi: https://doi.org/10.1101/2024.04.12.24305195

          (SNIP)


Like all viruses, Monkeypox continues to evolve and diversify, as discussed in the 2014 EID Journal article Genomic Variability of Monkeypox Virus among Humans, Democratic Republic of the Congo, where the authors cautioned:

Small genetic changes could favor adaptation to a human host, and this potential is greatest for pathogens with moderate transmission rates (such as MPXV) (40). The ability to spread rapidly and efficiently from human to human could enhance spread by travelers to new regions.

Which means we shouldn't be surprised if new variants, or subclades, of Mpox appear over time. Especially when very little has been done to curb the spread of the virus in endemic regions like the DRC. 

Complicating matters, recent studies suggest that the protective effects of the JYNNEOS vaccine - at least in those who had not received a smallpox vaccination - wanes over a period of months (see ECCMID 2024 Study: Mpox (monkeypox) Antibodies Wane Within A Year of Vaccination).

While there are no confirmed cases of this new clade outside of the DRC, borders and oceans no longer provide the barrier against the spread of infectious diseases they once did.  

A reminder that an infectious disease threat anywhere in the world is potentially a threat everywhere. 


CDC Guidance for Veterinarians: Evaluating & Handling Cats Potentially Exposed to HPAI H5N1



Cats As Potential Vectors/Mixing Vessels for Novel Flu

#18,010

We've known for more than 20 years that cats are susceptible to certain types of novel flu (see HPAI: Catch as Cats Can), including H5N1. In 2006, the WHO reported:

In February 2004, the (H5N1) virus was detected in a clouded leopard that died at a zoo near Bangkok. A white tiger died from infection with the virus at the same zoo in March 2004.

In October 2004, captive tigers fed on fresh chicken carcasses began dying in large numbers at a zoo in Thailand. Altogether 147 tigers out of 441 died of infection or were euthanized. Subsequent investigation determined that at least some tiger-to-tiger transmission of the virus occurred.

Since then we've a number of spillovers of both LPAI and HPAI to cats, including:

In late 2016, New York City reported hundreds of cats across several city-run animal shelters contracted avian an LPAI H7N2 (see NYC Health Dept. Statement On Avian H7N2 In Cats)

Studies later showed that two shelter workers were infected whil5 others exhibited low positive titers to the virus, suggesting possible infection (see J Infect Dis: Serological Evidence Of H7N2 Infection Among Animal Shelter Workers, NYC 2016). 

More recently, the United States has reported a number of spillovers of HPAI H5N1 into cats (see Nebraska Veterinary Diagnostic Center (NVDC) Report: 2 Domestic Cats Infected With HPAI H5N1), and last year both South Korea and Poland reported significant outbreaks in felines. 

Two weeks ago, CIDRAP confirmed that 3 cats had tested positive for HPAI H5 on at least one of the Texas dairy farms where cattle have been infected, and Cornell University - whose Animal Health Diagnostic Center has done some of the preliminary testing - reported:

Grackles and pigeons were found dead at the same facilities, alongside some farm cats. While samples from cows were being sequenced, tests from the birds and a cat performed in the Molecular Diagnostics Laboratory at the AHDC came back positive for HPAI. Analysis of the NGS data then detected influenza sequences in the nasal swabs and milk samples from the sick cows.

We recently reviewed the CDC's Updated Advice On Bird Flu in Pets and Other Animals, which warned the public to avoid contact between their pets (e.g., pet birds, dogs and cats) with wild birds

This week the CDC has published the following recommendations for Veterinarians who may come in contact with potentially exposed cats. 

Considerations for Veterinarians: Evaluating and Handling of Cats Potentially Exposed to Highly Pathogenic Avian Influenza A(H5N1) Virus
Español | Other Languages Print

Highly pathogenic avian influenza (HPAI) A(H5N1) virus is an influenza virus that causes what is known as “bird flu.” Although bird flu viruses mainly infect and spread among wild migratory water birds and domestic poultry, bird flu viruses have been shown to spread, although inefficiently, to mammals, including humans.

HPAI A(H5N1) infections in cats have been reported in the United States, Poland, South Korea, and France. These cats demonstrated varying degrees of clinical manifestations, including respiratory and neurological signs, and some had fatal outcomes. Infection is thought to have happened via exposure to infected birds or other animals.
In late March and early April 2024, Texas reported detection of HPAI A(H5N1) in several cats from several dairy farms experiencing HPAI A(H5N1) virus infections in dairy cows, suggesting the virus spread to the cats either from affected dairy cows, raw cow milk, or from wild birds associated with those farms.

While it’s unlikely that people would become infected with bird flu viruses through contact with an infected wild, stray, feral, or domestic cat, it is possible—especially if there is prolonged and unprotected exposure to the animal. Sick animals may be able to transmit influenza virus to people in their saliva, feces or droppings, and other body fluids. Human infections can occur when the virus is inhaled or gets into a person’s eyes, nose, or mouth. This can happen when virus is in the air (in droplets or dust) and a person breathes it in, or when a person touches something that has virus on it and then touches their mouth, eyes, or nose.

Veterinarians and veterinary staff, in field and clinical settings, who are working in close contact with cats who are suspected or confirmed-positive for HPAI A(H5N1) virus infection, including those who are sampling cats for HPAI A(H5N1) viruses, should take precautions to prevent potential unprotected exposures.

Recommendations for Worker Protection and Use of Personal Protective Equipment (PPE) to Reduce Exposure to Novel Influenza A Viruses Associated with Severe Disease in Humans may be adapted to veterinarians and veterinary staff who will have exposure to cats that are suspected or confirmed with HPAI A(H5N1) virus infection. Recommendations from this resource are below. Criteria for exposure are described in: Highly Pathogenic Avian Influenza A(H5N1) Virus in Animals: Interim Recommendations for Prevention, Monitoring, and Public Health Investigations | Avian Influenza (Flu) (cdc.gov)
  • Avoid unprotected close or direct physical contact with sick cats who may have been exposed to animals that tested positive for HPAI A(H5N1) virus infection.
  • When handling or interacting with cats that might be infected with or have been exposed to bird flu viruses, veterinarians and staff should wear PPE including:
    • Disposable or non-disposable fluid-resistant coveralls or gown*, and depending on task(s), add disposable or non-disposable waterproof apron
    • Any NIOSH Approved® particulate respirator (e.g., N95® or greater filtering facepiece respirator, elastomeric half mask respirator with a minimum of N95 filters)
    • Properly-fitted unvented or indirectly vented safety goggles** or a face shield if there is risk of liquid splashing onto the respirator
    • Rubber boots or rubber boot covers with sealed seams that can be sanitized or disposable boot covers for tasks taking a short amount of time
    • Disposable or non-disposable head cover or hair cover
    • Disposable or non-disposable gloves
* Preferably, fluid-resistant coveralls should be made of material that passes:
  • AATCC 42 ≤ 1 g and AATCC 127 ≥ 50 cm H2O or EN 20811 ≥ 50 cm H2O; or
  • ASTM F1670 (13.8 kPa); or
  • ISO 16603 ≥ 3.5 kPA
** Preferably, safety goggles should conform to ANSI Z87.1 that are marked at least Z87 D3
Use particular care during aerosol-generating procedures (i.e., intubation, dental procedures).

All PPE should be used in accordance with OSHA regulations found at 29 CFR 1910 Subpart I (Personal Protective Equipment) including identifying appropriate PPE based on a site-specific risk assessment. Workers must receive training on and demonstrate an understanding of when to use PPE; what PPE is necessary; what it looks like when PPE is properly fitted; how to properly put on, use, take off, dispose of, and maintain PPE; and the limitations of PPE.

Guidance for people exposed to birds that test positive for HPAI A(H5N1) can be considered for people exposed to cats or other animals that are suspected or confirmed with H5N1:
People exposed to HPAI A(H5N1)-infected birds or other animals (including people wearing recommended PPE) should be monitored for signs and symptoms of acute respiratory illness beginning after their first exposure and for 10 days after their last exposure.

N95 and NIOSH Approved are certification marks of the U.S. Department of Health and Human Services (HHS) registered in the United States and several international jurisdictions.

Last Reviewed: April 15, 2024
Source: Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases (NCIRD)


While cat-to-human transmission of influenza viruses has only rarely been documented, HPAI H5 continues to exceed our expectations, and some extra precautions are warranted. 

Tuesday, April 16, 2024

Referral: IJID Editorial Avian `Bird' Flu - Undue Media Panic or Genuine Pandemic Concern?

H5N1 Virus - Photo Credit CDC PHIL 


#18,009


Although influenza viruses are notoriously unpredictable, it is no secret that HPAI H5 has been making disconcerting moves the past few years, and that there are legitimate concerns that it could better adapt to humans and possibly spark a pandemic. 
 
The recent spillover into cattle is only the latest in a series of red flags.  Tens of thousands of marine mammals have been infected, and have died, over the past two years, as well as tens of millions of birds.   

Personally, my biggest concern is that the virus spills over into swine, which could afford it additional opportunities to reassort with human and/or swine influenza A viruses.  But even if that doesn't happen, the virus seems to be on a perilous trajectory. 

While some of the `worst-case scenarios' being bandied about online, or in the tabloids, are probably overblown (see Revisiting the H5N1 CFR Debate), anything over a 1% fatality rate would be devastating.

Yesterday the IJID (International Journal of Infectious Diseases) published an open-access editorial on HPAI's growing pandemic potential, where they caution:

The recent incident of A(H5N1) in dairy cattle and the human infection is a wake-up call for action

Rather than post excerpts, I'll simply invite my reader to follow the link to read the editorial in its entirety.  I'll have a bit more after you return.



Ziad A MemishDavid S HuiLucille BlumbergShui- Shan LeeAlimuddin Zumla
Show all authors
Open Access Published: April 15, 2024 DOI:https://doi.org/10.1016/j.ijid.2024.107062

This editorial follows similar cautionary articles over the past week, which include:

JAVMA: HPAI in Wildlife: A Changing Disease Dynamic

AJVR: The Virus is Out of the Barn: The Emergence of HPAI

There is little doubt that experts around the world are increasingly worried. Hopefully another pandemic isn't imminent, but we would be prudent to prepare as if it were. 

HPAI H5N5: A Variation On A Theme

HPAI H5N5 WAHIS Updates for 2024
 

#18,008

This week WOAH reported (see below) more detections of HPAI H5N5 (clade 2.3.4.4b) virus in raccoons from Nova Scotia and Prince Edward Island.  The virus had previously been detected in wild birds, but turned up in dead raccoons on Prince Edward Island a year ago (see CIDRAP Report Canada reports first H5N5 avian flu in a mammal).

We report additional cases of highly pathogenic avian influenza Fully Eurasian H5N5 (2.3.4.4b) virus in raccoons from Nova Scotia and Prince Edward Island. Outbreaks are reported by province/territory. The geographical marker is on the capital. For detailed and current information on high pathogenicity avian influenza cases in wildlife, please consult : http://www.cwhc-rcsf.ca/avian_influenza.php.

While our biggest concern is currently HPAI H5N1, we've seen closely related H5N3, H5N4, H5N5, H5N6, and H5N8 viruses - the product of H5N1 reassorting with other LPAI viruses - infecting both birds and mammals around the globe. 

The H5N5 avian subtype first came to light in a 2011 report (see EID Journal: Novel H5N5 Avian Influenza Detected In China), which described the isolation of two novel reassortant HPAI H5N5 viruses from apparently healthy domestic ducks in Eastern China.

Several of the same authors wrote about additional isolates of the H5N5 virus in the journal Veterinary Microbiology (see Characterization of three H5N5 and one H5N8 highly pathogenic avian influenza viruses in China), that were isolated in China in 2009-10, suggesting that the first detection wasn’t a fluke.

Although we have looked at the the threat and evolution of HPAI H5N5 a number of times in the past (see here, here, and here), recent changes to clade 2.3.4.4b viruses probably make findings before 2021 less relevant. 

In June of 2022, in Norwegian Veterinary Institute : HPAI Detected In Arctic (Svalbard) For the First Timeboth H5N1 and H5N5 were detected (see press release below).

Published 21.06.2022 Modified 22.06.2022

In recent weeks, an abnormally high number of sick and dead birds has been observed in several places along the Norwegian coast. In May and June, the Veterinary Institute detected highly pathogenic avian influenza (HPAI) of subtype H5N5 in sea eagles, ravens, crows and several gull species in Troms and Finnmark. In the North Sea and along the coast in Rogaland, a high number of dead ospreys have been observed, and HPAI of the subtype H5N1 has been detected in several of these. In addition, HPAI has been detected in wild birds in Oslo, Bergen and several places in Trøndelag and Møre og Romsdal.

In the most recent ECDC/EFSA Quarterly Avian Influenza Overview Dec 2023 - Mar 2024, there were several mentions of HPAI H5N5, including:

  • Subtype A(H5N5), genotype EA-2021-I, which has persistently been detected in Norway since the 2021–2022 epidemiological year, has since September 2023 spread to Iceland, the United Kingdom, Greenland and Germany, and – besides infecting wild birds – infected red foxes in Norway. A(H5N5) was also detected in Faroe Islands and Japan during the current epidemiological year.
  • Unlike the mammalian infections reported in Europe during the summer months in 2023, mainly caused by the EA-2022-BB genotype, the recent A(H5) viruses identified in wild mammals belonged to different A(H5N1) and A(H5N5) genotypes. The detection of A(H5N5) virus in two red foxes from Norway represents the first detection of this subtype in mammals in Europe.

HPAI H5 is a highly promiscuous virus, capable of reassorting with a variety of other influenza A viruses.  It continually spins off new genotypes (including new subtypes) as it spreads, some potentially being more dangerous than others.

It is for this reason there is so much concern about HPAI H5 spilling over into pigs, which would give it access to a wide array of swine and human viruses. 
 

But other species, including humans, marine mammals, mink, and even dogs and cats could serve as an effective `mixing vessel'. 

Six years ago, HPAI H5N8 was the dominant H5 subtype, but was supplanted by H5N1 in 2020. It is entirely possible that we could seen another shift - from H5N1 to H5N5, or H5N6, or to some other n-type, in the months or years ahead.

And while clade 2.3.4.4b is currently in the driver's seat, we've seen a resurgence in clade 2.3.2.1c in Cambodia over the past year, and last week the FAO warned of a Reassortment Between H5N1 Clade 2.3.4.4b & Clade 2.3.2.1c Viruses In Mekong Delta Region.   

While we expect all influenza A viruses to change over time, HPAI H5 seems to be working overtime. 

Which is why we need to be prepared for more surprises.